These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8595534)

  • 1. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists.
    Stempel DA; Durcannin-Robbins JF; Hedblom EC; Woolf R; Sturm LL; Stempl AB
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):153-8. PubMed ID: 8595534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease management program for asthma: baseline assessment of resource use.
    MacKinnon NJ; Flagstad MS; Peterson CR; Mesch-Beatty K
    Am J Health Syst Pharm; 1996 Mar; 53(5):535-41. PubMed ID: 8697013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the Asthma Outcomes Registry.
    Huse DM; Russell MW; Weiss ST; Hartz SC
    Am J Manag Care; 2000 Sep; 6(9):1045-50. PubMed ID: 11184066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population.
    Nestor A; Calhoun AC; Dickson M; Kalik CA
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between asthma drug therapy patterns and healthcare utilization.
    Shireman TI; Heaton PC; Gay WE; Cluxton RJ; Moomaw CJ
    Ann Pharmacother; 2002 Apr; 36(4):557-64. PubMed ID: 11918499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures.
    Stempel DA; Hedblom EC; Durcanin-Robbins JF; Sturm LL
    Arch Fam Med; 1996 Jan; 5(1):36-40. PubMed ID: 8542052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost comparison of beta 2-agonist bronchodilators used in the treatment of asthma.
    Nightingale CH
    Pharmacotherapy; 1995; 15(5):677-81. PubMed ID: 8570443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.
    Piecoro LT; Potoski M; Talbert JC; Doherty DE
    Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
    Price DB; Ben-Joseph RH; Zhang Q
    Respir Med; 2001 Jan; 95(1):83-9. PubMed ID: 11207023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids.
    Diette GB; Wu AW; Skinner EA; Markson L; Clark RD; McDonald RC; Healy JP; Huber M; Steinwachs DM
    Arch Intern Med; 1999 Dec 13-27; 159(22):2697-704. PubMed ID: 10597760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS
    J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study.
    Breekveldt-Postma NS; Erkens JA; Aalbers R; van de Ven MJ; Lammers JW; Herings RM
    Curr Med Res Opin; 2008 Apr; 24(4):975-83. PubMed ID: 18282372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s.
    David C
    J Asthma; 2004 Sep; 41(6):655-61. PubMed ID: 15584315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.
    Lozano P; Fishman P; VonKorff M; Hecht J
    Pediatrics; 1997 Jun; 99(6):757-64. PubMed ID: 9164766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma.
    Rank MA; Liesinger JT; Branda ME; Gionfriddo MR; Schatz M; Zeiger RS; Shah ND
    J Allergy Clin Immunol; 2016 May; 137(5):1373-1379.e3. PubMed ID: 26506020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.